semaglutide prediabetes weight loss trial progression to diabetes Two-year effects of in adults with overweight or obesity: the STEP 5 Semaglutide results week by week:

Bile acids modulate gastric emptying as well as small and intestinal colonic motility

HIGH ABSORPTION MAGNESIUM CITRATE: Each serving delivers 200-300mg of highly bioavailable Magnesium Citrate to support relaxation, nerve function without the digestive discomfort often associated with other magnesium forms

Between 30 million and 50 million US adults could be taking a GLP-1 by 2034. In December 2024, 1.9 million prescriptions of GLP-1s to treat obesity (as opposed to diabetes, for example) were filled, nearly quadruple the number YoY, per IQVIA

Shares of Eli Lilly and Company (NYSE:LLY) slipped around 2% after the latest weekly prescription data pointed to mixed trends across its GLP-1 drug portfolio

As expanded insurance coverage is expected to significantly improve access to costly therapies, substantial changes are anticipated across both the obesity treatment market and broader healthcare paradigms.

this finding should be interpreted cautiously given the retrospective design, active and non-inert comparator, and likelihood of residual confounding